Recap: Landos Biopharma Q4 Earnings

Landos Biopharma LABP reported its Q4 earnings results on Thursday, March 21, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Landos Biopharma missed estimated earnings by -9.0%, reporting an EPS of $-0.99 versus an estimate of $-0.91.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 7.000000000000001% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Landos Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.